|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Sales – net | |||||
| Costs and Expenses | |||||
| Cost of sales | |||||
| Operating expenses | |||||
| Impairment of fixed assets | |||||
| Gross margin | |||||
| General and administrative expenses | |||||
| Depreciation and amortization | |||||
| Impairment loss | |||||
| Total costs and expenses | |||||
| Loss from operations | |||||
| Other income (expense) | |||||
| Interest income | |||||
| Other income | |||||
| Interest expense | |||||
| Gain (loss) on settlement of liabilities | |||||
| Other income | |||||
| Interest expense (including amortization of debt discount) | |||||
| Loss on sale of marketable debt securities - net | |||||
| Total other income (expense) - net | |||||
| Net loss | |||||
| Non-controlling interest | |||||
| Non-controlling interest before preferred stock dividends | |||||
| Total comprehensive loss: | |||||
| Preferred stock dividend | |||||
| Series A Convertible Preferred Stock | |||||
| Series B Convertible Preferred Stock | |||||
| Preferred stock dividend | |||||
| Series A Convertible Preferred Stock | |||||
| Series B Convertible Preferred Stock | |||||
| Net loss available to common stockholders diluted | |||||
| Net loss available to common stockholders - basic | |||||
| Basic loss per share | |||||
| Diluted loss per share | |||||
| Weighted average number of shares - basic | |||||
| Weighted average number of shares - diluted | |||||
Loading...